Fate Therapeutics Inc share price logo

Fate Therapeutics Inc Share Price

NASDAQ: FATE

Small Cap

$1.00

+0.05

(+5.24%)

as on

Fate Therapeutics Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $0.97
    $1.02
    downward going graph

    3.00%

    Downside

    2.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.66
    $4.2
    downward going graph

    33.89%

    Downside

    320.00%

    Upside

    downward going graph

Fate Therapeutics Inc share price movements today

Previous Close
$0.95
Open
$0.98
Volume
2.1M
Day's Low - High
$0.97 - $1.02
52 Week Low - High
$0.66 - $4.2

Fate Therapeutics Inc Historical Returns

1 Month Return
-20.83 %
3 Month Return
-21.49 %
1 Year Return
-75.52 %
3 Year Return
-96.2 %
5 Year Return
-97.58 %

Fate Therapeutics Inc Stock Fundamentals & Key Indicators

Check Fate Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$109.6M

EPS (TTM)

-1.1021

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.29

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

0

EBITDA

-161.6M

Revenue (TTM)

8.5M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Fate Therapeutics Inc Stock Valuation

Track how Fate Therapeutics Inc P/E has moved over time to understand its valuation trends.

Fate Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 18, 2025

Industry (-3.94x)

September 18, 2025

Today (-2.29x)

September 18, 2025

Highest (-0.82x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.29x

Fate Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fate Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
HOLD$109.6M-97.58%-2.290.00%
NA$38.7BNANA-3.89%
BUY$60.5B241.54%-505.15-12.96%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Fate Therapeutics Inc Stock including INR - Dollar returns

The Fate Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Fate Therapeutics Inc investment value today

Current value as on today

₹30,726

Returns

₹69,274

(-69.27%)

Returns from Fate Therapeutics Inc Stock

₹74,227 (-74.23%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Fate Therapeutics Inc Stock

Based on 26 analysts

HOLD

42.31%

Buy

53.85%

Hold

3.85%

Sell

Based on 26 analysts, 53.85% of analysts recommend a 'HOLD' rating for Fate Therapeutics Inc. Average target price of $4.45

Fate Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Fate Therapeutics Inc.

What analysts predicted

77.53%UPSIDE

Target Price

$4.45

Current Price

$1

Analyzed by

26 Analysts

Target

$4.45

Fate Therapeutics Inc target price $4.45, a slight upside of 77.53% compared to current price of $1. According to 26 analysts rating.

Fate Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Fate Therapeutics Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Fate Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
58
0
1
1
1
6
3
1
1
1
Gross Profit
54
-3
-2
-3
-2
2
3
1
1
-1
Operating Income
-28
-62
-51
-48
-51
-45
-52
-61
-41
-36
EBITDA
-24
-58
-46
-43
-46
-40
-47
-42
-37
-36
Interest Expense
9
-
-
9
-
-
-
-
-
-
Depreciation
4
4
4
4
4
4
4
4
3
3
Income Before Tax
-18
-52
-45
-44
-48
-38
-47
-52
-37
-34
Income Tax Expense
-9
-4
-4
18
4
-
-
-4
-
-
Net Income
-9
-52
-45
-44
-48
-38
-47
-52
-37
-34
Net Profit Margin
-15.55%
-5654.34%
-2323.56%
-2632.58%
-2493.71%
-567.44%
-1551.01%
-2803.92%
-2309.45%
-1786.58%

Fate Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
4
4
4
10
31
55
96
63
13
Gross Profit
-17
-22
-30
-51
-77
-94
49
96
-93
13
Operating Income
-27
-31
-42
-67
-100
-128
-216
-308
-190
-210
EBITDA
-27
-30
-40
-63
-94
-124
-211
-294
-172
-176
Interest Expense
2
1
1
1
1
2
4
5
-
-
Depreciation
-
-
0
1
2
3
5
13
18
18
Income Before Tax
-29
-33
-42
-66
-98
-173
-212
-281
-160
-186
Income Tax Expense
0
0
0
2
0
-3
-5
-26
18
-
Net Income
-29
-33
-42
-66
-97
-173
-212
-255
-160
-186
Net Profit Margin
-1233.73%
-760.15%
-1046.08%
-1405.02%
-914.87%
-551.59%
-379.89%
-264.86%
-253.30%
-1366.46%

Fate Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-52
-45
-44
-48
-38
-47
-52
-37
-34
Operating Cash Flow
-28
-38
-36
-33
-32
-29
-27
-33
-24
Investing Cash Flow
33
24
45
17
-53
25
22
42
19
Financing Cash Flow
0
-
0
95
1
-
3
-
1
Change in Cash
4
-13
8
79
-84
-3
-1
8
-3

Fate Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-33
-42
-66
-98
-173
-212
-281
-160
-186
Operating Cash Flow
-29
-36
-38
-83
-39
-162
-248
-132
-122
Investing Cash Flow
-4
-10
0
-157
-161
-324
166
112
12
Financing Cash Flow
57
47
140
149
282
453
9
0
99
Change in Cash
23
0
101
-90
82
-33
-72
-19
-10

Global Institutional Holdings in Fate Therapeutics Inc

Funds
Holdings
Redmile Group, LLC
11.23%
BlackRock Inc
9.32%
Vanguard Group Inc
8.99%
Schonfeld Strategic Advisors LLC
6.8%
Citadel Advisors Llc
3.74%

Insights on Fate Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.62M → 1.90M (in $), with an average increase of 14.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -52.15M → -34.07M (in $), with an average increase of 24.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 67.3% return, outperforming this stock by 143.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Beone Medicines Ltd has given 114.6% return, outperforming this stock by 210.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, FATE stock has moved down by -16.7%

About Fate Therapeutics Inc

fate therapeutics is applying leading expertise in stem cell biology and conventional drug discovery to develop small molecule and biologic drugs that: 1) activate stem cells in the body to stimulate healing and repair or block cancer growth; and 2) create and differentiate "pharmaceutical grade"​ ips cells to enable their use in drug discovery and development, disease modeling, and eventually personalized cell therapies. the company’s approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases.
OrganisationFate Therapeutics Inc
Headquarters12278 Scripps Summit Drive, San Diego, CA, United States, 92131
IndustryHealth Technology
CEODr. Bahram Valamehr M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Fate Therapeutics Inc

Name

Title

Ms. Kate Duvall

Corporate Controller

Dr. Bahram Valamehr M.B.A., Ph.D.

President, CEO & Director

Ms. Cindy R. Tahl J.D.

Chief Legal & Compliance Officer and Corporate Secretary

Mr. Victor Hong

Vice President of Corporate Development & Finance

Ms. Jessica Francis

Vice President Of Human Resources & Operations

Mr. Andrew Henry

Senior Vice President of Clinical Operations

Dr. Tunde Babalola

Senior Vice President of Technical Operations

Dr. Yu Cai

Head of Intellectual Property & Assistant General Counsel

FAQs

What is Fate Therapeutics Inc share price today?

Fate Therapeutics Inc share price today is $1 as on at the close of the market. Fate Therapeutics Inc share today touched a day high of $1.02 and a low of $0.97.

What is the 52 week high and 52 week low for Fate Therapeutics Inc share?

Fate Therapeutics Inc share touched a 52 week high of $4.2 on and a 52 week low of $0.66 on . Fate Therapeutics Inc stock price today i.e. is closed at $1,which is 76.19% down from its 52 week high and 51.27% up from its 52 week low.

What is Fate Therapeutics Inc's market capitalisation today?

Fate Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Fate Therapeutics Inc Stock (FATE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Fate Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fate Therapeutics Inc Shares that will get you 1.5000 shares as per Fate Therapeutics Inc share price of $1 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Fate Therapeutics Inc Stock (FATE) from India?

Indian investors can start investing in Fate Therapeutics Inc (FATE) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Fate Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Fate Therapeutics Inc share’s latest price of $1 as on September 19, 2025 at 1:29 am IST, you will get 10.0000 shares of Fate Therapeutics Inc. Learn more about fractional shares .

What are the returns that Fate Therapeutics Inc has given to Indian investors in the last 5 years?

Fate Therapeutics Inc stock has given -97.58% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?